-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ShDVTTeM0QdNiUtbjflNTesbhcVlFRkeaOhwQXoPkiBDdFq9yqb/CwRNxzpwQ7B/ jJxYqoKXBO/dJ3q0VV2wPQ== 0001140361-10-013043.txt : 20100322 0001140361-10-013043.hdr.sgml : 20100322 20100322123006 ACCESSION NUMBER: 0001140361-10-013043 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20100318 FILED AS OF DATE: 20100322 DATE AS OF CHANGE: 20100322 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MORVILLE MALCOLM CENTRAL INDEX KEY: 0001244152 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32639 FILM NUMBER: 10696011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001001316 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 363898269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 810 SEVENTH AVENUE STREET 2: 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: (212) 582-3950 MAIL ADDRESS: STREET 1: 810 SEVENTH AVENUE STREET 2: 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC DATE OF NAME CHANGE: 20000330 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960703 3 1 doc1.xml FORM 3 X0203 3 2010-03-18 0 0001001316 MANHATTAN PHARMACEUTICALS INC MHAN 0001244152 MORVILLE MALCOLM C/O MANHATTAN PHARMACEUTICALS, INC. 48 WALL STREET, SUITE 1110 NEW YORK NY 10005 1 0 0 0 Common Stock, $0.001 par value per share 211568 D /s/ Malcolm Morville, By: Michael McGuinness, Attorney-in-Fact 2010-03-22 EX-24.1 2 poa1.htm POWER OF ATTORNEY Unassociated Document
 
POWER OF ATTORNEY FOR DIRECTORS OF
MANHATTAN PHARMACEUTICALS, INC.

Know all by these presents, that the undersigned hereby constitutes and appoints Michael McGuinness his true and lawful attorney-in-fact to:

 
1.
execute for and on behalf of the undersigned Form ID, Schedules 13D and 13G, and Forms 3, 4 and 5 in accordance with Sections 13 and 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;

 
2.
do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete the execution of any such Form ID, Schedules 13D or 13G, and Forms 3, 4 or 5 and the timely filing of such Forms with the United States Securities and Exchange Commission and any other authority; and

 
3.
take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, including without limitation the execution and filing of a Form 4 with respect to a transaction which may be reported on a Form 5, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in his/her discretion.

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform all and every act and thing whatsoever requisite, necessary and proper to be done in the exercise of any of the rights and powers herein granted, as fully and to all intents and purposes as he might or could do in person, with full power of substitution and resubstitution, hereby ratifying and confirming all that such attorney-in-fact, or his/her substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted.  The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming any of the undersigned's responsibilities to comply with Sections 13 or 16 of the Securities Exchange Act of 1934.

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 18th day of March, 2010.


 
/s/ Malcolm Morville
 
Name: Malcolm Morville
 
A director of Manhattan Pharmaceuticals, Inc.


-----END PRIVACY-ENHANCED MESSAGE-----